首页|硫酸镁与盐酸利托君治疗前置胎盘的疗效研究

硫酸镁与盐酸利托君治疗前置胎盘的疗效研究

扫码查看
目的 探究前置胎盘应用硫酸镁与盐酸利托君的临床疗效及安全性,为前置胎盘的临床治疗提供依据.方法 选取2018年11月-2020年11月高唐县人民医院收治的78例前置胎盘患者,按照随机数字表法分为观察组和对照组各39例.对照组给予硫酸镁治疗,观察组给予盐酸利托君治疗.比较两组孕周延长时间、产后出血量、新生儿Apgar评分、新生儿体质量、妊娠足月率、保胎成功率、阴道分娩率及不良反应发生率.结果 观察组孕周延长时间长于对照组,产后出血量少于对照组,新生儿Apgar评分及新生儿体质量均优于对照组,差异均有统计学意义(P<0.05).观察组妊娠足月率、保胎成功率及阴道分娩率为92.31%、94.87%及92.31%,均高于对照组的69.23%、76.92%及71.79%,差异均有统计学意义(P<0.05).观察组不良反应发生率为5.13%,对照组不良反应发生率为10.26%,两组比较差异无统计学意义(x2=0.1806,P>0.05).结论 前置胎盘应用盐酸利托君治疗效果良好,可有效延长孕周,降低产后出血量,提高保胎成功率及阴道分娩率,具有一定安全性,值得临床应用推广.
Study on the efficacy of magnesium sulfate and ritodrine hydrochloride in the treatment of placenta previa
Objective To explore the clinical efficacy and safety of magnesium sulfate and ritodrine hydrochloride in the treatment of placenta previa,and to provide a basis for the clinical treatment of placenta previa.Methods A total of 78 patients with placenta previa admitted to Gaotang County People's Hospital from November 2018 to November 2020 were selected and divided into an observation group and a control group according to the random number table method,with 39 cases in each group.The control group was treated with magnesium sulfate,while the observation group was treated with ritodrine hydrochloride.The time of gestational week extension,postpartum bleeding volume,neonatal Apgar score,neonatal body weight,full-term pregnancy rate,success rate of fetal preservation,vaginal delivery rate and incidence of adverse reactions between two groups were compared.Results The time of gestational week extension in the observation group was longer than that in the control group,postpartum bleeding volume was less than that in the control group,the Apgar score and body weight of newborns in the observation group were better than those in the control group,and the differences were statistically significant(P<0.05).The full-term pregnancy rate,success rate of fetal preservation and vaginal delivery rate in the observation group were 92.31%,94.87%and 92.31%,which were all higher than those in the control group with 69.23%,76.92%and 71.79%,and the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was 5.13%,while the incidence of adverse reactions in the control group was 10.26%,and the difference was not statistically significant between the two groups(x2=0.180 6,P>0.05).Conclusion The application of ritodrine hydrochloride in the treatment of placenta previa had good therapeutic effects,could effectively prolong gestational week,reduce postpartum bleeding volume,improve the success rate of fetal preservation and vaginal delivery rate,and had certain safety,which was worthy of clinical application and promotion.

Magnesium sulfateRitodrine hydrochloridePlacenta previaClinical efficacySafety

赵淑彤

展开 >

高唐县人民医院妇产科,山东 聊城 252800

硫酸镁 盐酸利托君 前置胎盘 临床疗效 安全性

2024

中国城乡企业卫生
中华预防医学会 天津市职业病防治院

中国城乡企业卫生

影响因子:0.239
ISSN:1003-5052
年,卷(期):2024.39(1)
  • 10